These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31924844)

  • 1. In silico analysis of alternative splicing on drug-target gene interactions.
    Ji Y; Mishra RK; Davuluri RV
    Sci Rep; 2020 Jan; 10(1):134. PubMed ID: 31924844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternatively Spliced Homologous Exons Have Ancient Origins and Are Highly Expressed at the Protein Level.
    Abascal F; Ezkurdia I; Rodriguez-Rivas J; Rodriguez JM; del Pozo A; Vázquez J; Valencia A; Tress ML
    PLoS Comput Biol; 2015 Jun; 11(6):e1004325. PubMed ID: 26061177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural implication of splicing stochastics.
    Melamud E; Moult J
    Nucleic Acids Res; 2009 Aug; 37(14):4862-72. PubMed ID: 19528068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecdysteroid-responsive genes, RXR and E75, in the tropical land crab, Gecarcinus lateralis: differential tissue expression of multiple RXR isoforms generated at three alternative splicing sites in the hinge and ligand-binding domains.
    Kim HW; Lee SG; Mykles DL
    Mol Cell Endocrinol; 2005 Oct; 242(1-2):80-95. PubMed ID: 16150535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splice-mediated Variants of Proteins (SpliVaP) - data and characterization of changes in signatures among protein isoforms due to alternative splicing.
    Floris M; Orsini M; Thanaraj TA
    BMC Genomics; 2008 Oct; 9():453. PubMed ID: 18831736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network-based method for drug target discovery at the isoform level.
    Ma J; Wang J; Ghoraie LS; Men X; Liu L; Dai P
    Sci Rep; 2019 Sep; 9(1):13868. PubMed ID: 31554914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APPRIS 2017: principal isoforms for multiple gene sets.
    Rodriguez JM; Rodriguez-Rivas J; Di Domenico T; Vázquez J; Valencia A; Tress ML
    Nucleic Acids Res; 2018 Jan; 46(D1):D213-D217. PubMed ID: 29069475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APPRIS: annotation of principal and alternative splice isoforms.
    Rodriguez JM; Maietta P; Ezkurdia I; Pietrelli A; Wesselink JJ; Lopez G; Valencia A; Tress ML
    Nucleic Acids Res; 2013 Jan; 41(Database issue):D110-7. PubMed ID: 23161672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative splicing of the LIM-homeodomain transcription factor Isl1 in the mouse retina.
    Whitney IE; Kautzman AG; Reese BE
    Mol Cell Neurosci; 2015 Mar; 65():102-13. PubMed ID: 25752730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer.
    Yang IS; Son H; Kim S; Kim S
    BMC Genomics; 2016 Aug; 17(1):631. PubMed ID: 27519173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the functional impact of alternative splicing on human protein isoforms using available annotation sources.
    Sulakhe D; D'Souza M; Wang S; Balasubramanian S; Athri P; Xie B; Canzar S; Agam G; Gilliam TC; Maltsev N
    Brief Bioinform; 2019 Sep; 20(5):1754-1768. PubMed ID: 29931155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology.
    Black DL
    Cell; 2000 Oct; 103(3):367-70. PubMed ID: 11081623
    [No Abstract]   [Full Text] [Related]  

  • 13. Domain-based prediction of the human isoform interactome provides insights into the functional impact of alternative splicing.
    Ghadie MA; Lambourne L; Vidal M; Xia Y
    PLoS Comput Biol; 2017 Aug; 13(8):e1005717. PubMed ID: 28846689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of isoform expression from splicing array using multiple comparisons.
    Nair TM
    Methods Mol Biol; 2012; 802():113-21. PubMed ID: 22130877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel alternative splicing isoform biomarkers identification from high-throughput plasma proteomics profiling of breast cancer.
    Zhang F; Wang M; Michael T; Drabier R
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S8. PubMed ID: 24565027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splice Expression Variation Analysis (SEVA) for inter-tumor heterogeneity of gene isoform usage in cancer.
    Afsari B; Guo T; Considine M; Florea L; Kagohara LT; Stein-O'Brien GL; Kelley D; Flam E; Zambo KD; Ha PK; Geman D; Ochs MF; Califano JA; Gaykalova DA; Favorov AV; Fertig EJ
    Bioinformatics; 2018 Jun; 34(11):1859-1867. PubMed ID: 29342249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating splice-isoform expression into genome-scale models characterizes breast cancer metabolism.
    Angione C
    Bioinformatics; 2018 Feb; 34(3):494-501. PubMed ID: 28968777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of regulatory targets of alternative isoforms of the epidermal growth factor receptor in a glioblastoma cell line.
    Weinholdt C; Wichmann H; Kotrba J; Ardell DH; Kappler M; Eckert AW; Vordermark D; Grosse I
    BMC Bioinformatics; 2019 Aug; 20(1):434. PubMed ID: 31438847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic evaluation of isoform function in literature reports of alternative splicing.
    Bhuiyan SA; Ly S; Phan M; Huntington B; Hogan E; Liu CC; Liu J; Pavlidis P
    BMC Genomics; 2018 Aug; 19(1):637. PubMed ID: 30153812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curated multiple sequence alignment for the Adenomatous Polyposis Coli (APC) gene and accuracy of in silico pathogenicity predictions.
    Karabachev AD; Martini DJ; Hermel DJ; Solcz D; Richardson ME; Pesaran T; Sarkar IN; Greenblatt MS
    PLoS One; 2020; 15(8):e0233673. PubMed ID: 32750050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.